TheScreener
Fundamental and technical screening for 1,000 listed companies.
Use ⌘K to search stocks, screens, and features instantly.
Shaily Engineering Plastics Ltd.
SHAILYMid CapNSEBSE
Chemicals - Plastics & Rubber · Consumer Durables
₹3,278.80down 10.20down 0.31 percentas of 28 Aug 2026
Book value ₹156.36Div yield 0.15%
Key metrics
- Market Cap
- 15,352.62 ₹ cr
- P/E
- 88.80 x
- P/B
- 20.97 x
- ROE
- 23.71%
- ROCE
- 29.37%
- Debt to Equity
- 0.25 x
- Net Margin
- 17.15%
- Dividend Yield
- 0.15%
- Revenue Growth (YoY)
- 13.77%
Observations
Mechanical observations generated from stored data, not analysis or opinion. Each one names the threshold that produced it — the ROCE check below uses 20%, a fixed default rather than a value tailored to this company.
- ROCE above 20% in 2 of the last 3 financial years (2023-2024, 2024-2025, 2025-2026).
- Revenue grew year-on-year in each of the last 3 years.
- Net margin grew year-on-year in each of the last 3 years.
- Promoter holding 41.1% (pledge data not available).
- Debt-to-equity 0.25 — below the Consumer Durables median of 0.38.
SHAILY
₹3,278.80down 0.31 percent
EOD Synced: 28 Aug 2026 18:30 ISTOverview & Live Price Chart
Executive Investment Verdict & Quality Synthesis
Autonomous V2Multi-dimensional quantitative synthesis across capital efficiency, forensic accounting, intrinsic valuation, and ownership governance.
Factual Quantitative Consensus
1. Capital Efficiency & MoatHigh ROCE Compounder
29.37%ROCE
ROE: 23.71%·P/B: 20.97x
2. Forensic Health & SolvencyPiotroski 9/9 · Strong Health
9/9Piotroski Score
Altman: 5.6 (Safe Zone)
3. Valuation & DCF Spread-95.2% Valuation Premium
₹157DCF Fair Value
CMP: ₹3,278.8
4. Ownership & GovernanceClean Promoter Holding
41.09%Promoter Stake
Pledged: 0.0%·Inst: 30.18%
Institutional Factor Scores
QVGM Factor Grade Matrix
Institutional Multi-Factor Profile (QVGM)
Composite 0–100 percentile ranks normalized across all 500 universe constituents
Rank #2 of 5 in Chemicals - Plastics & RubberQVGM 62/100
Quality (Q)78
ROE, ROCE, Margins & Cash Conversion
Value (V)9
P/E, P/B, EV/EBITDA vs Sector Benchmarks
Growth (G)80
3Y Sales & EPS Compounded Growth
Momentum (M)84
Relative Strength & Trend Position
TheScreener Radar™ 5-Pillar Quantitative Scorecard
Holistic quantitative radar evaluating fundamental quality, valuation multiples, balance sheet health, growth, and price momentum
Sector Rank:Rank #2 of 5 in Chemicals - Plastics & Rubber
Valuation
Weak9/100
P/E Ratio:88.80x
P/B Ratio:20.97x
Dividend Yield:0.15%
P/E, P/B, EV/EBITDA & Dividend Yield relative to 5Y medians and sector
Growth
Strong80/100
3Y Sales CAGR:—
3Y PAT CAGR:—
Quarterly YoY:+12.4%
3-Year Compounded Sales & Net Profit Growth trajectory
Profitability
Strong78/100
ROE:23.7%
ROCE:29.4%
OPM %:—
Return on Equity (ROE), ROCE & Operating Margin efficiency
Solvency & Health
Strong100/100
Piotroski F-Score:9/9
Altman Z-Score:5.62
Debt / Equity:0.00
Balance Sheet strength, Altman Z-Score & Piotroski F-Score checklist
Momentum
Strong84/100
1Y Return:—
RSI (14):54.2
From 52W High:—
1-Year Relative Strength vs NIFTY 500, RSI-14 & 52W High distance
Quantitative Drivers & Growth Analysis
52-week corridor, deep valuation multiples, compounded CAGR trajectory, and institutional flow shifts
52-Week Low₹1,821.60
From 52W High-5.18%
52-Week High₹3,457.90
Valuation MultiplesCash Flow & Yield
PEG Ratio1.29
Earnings Yield1.12%
Price / FCF382.57
FCF Yield0.26%
Payout Ratio13.58%
Net-Net Ratio0.13
Solvency & SafetyPiotroski & Altman
Piotroski F-Score9/9
Altman Z-Score5.62
Graham Number₹359.96
1Y Flow & Margin ShiftsTrailing 12M
FII Stake:▲ +1.45%
DII Stake:▲ +3.27%
OPM Margin:▲ +6.27%
Net Margin:▲ +5.32%
Compounded Annual Growth Rate (CAGR Matrix)
Historical Fundamental Trajectory| Metric | QoQ Shift | YoY Shift | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|
| Revenue Growth | ▲ +18.52% | ▲ +13.77% | 25.91% | 17.73% | 22.40% |
| Net Profit Growth | ▲ +19.55% | ▲ +16.76% | 82.46% | 69.08% | 50.48% |
| EPS Growth | ▲ +19.93% | ▲ +16.70% | 82.15% | 68.78% | 47.42% |
Intrinsic Valuation Models & DCF Sensitivity
Institutional DCF & Intrinsic Valuation Studio — SHAILY
2-Stage Discounted Cash Flow, Reverse DCF Implied Growth, and Benjamin Graham & Peter Lynch valuation benchmarks.
DCF Intrinsic Fair Value
₹165.9
Verdict:Overvalued (-94.9%)
Benjamin Graham Number
₹359.3
-89% vs CMPPeter Lynch Fair Value
₹1,841.5
-43.8% vs CMPReverse DCF Implied Growth
60.0% CAGR
Aggressive Expectations (Priced for Perfection)Valuation Spectrum PositioningCMP: ₹3,278.8
₹0 (Distress)CMP: ₹3,279DCF: ₹166Graham: ₹359
Scenario Calibration & Sensitivity Levers
Tune Discount Rate (WACC), 5-Year Growth, and Terminal Value to model bear, base, and bull cases.
Discount Rate (WACC)11.5%
Cost of Capital Hurdle
5-Year FCF Growth CAGR13.0%
Assumed stage-1 cash flow expansionTerminal Growth Rate4.5%
Long-term perpetual GDP growth rate5-Year Projected Cash Flow Schedule (₹ Cr)
| Projection Period | Growth Rate | Projected FCF | Discount Factor | Present Value |
|---|---|---|---|---|
| Year 1 | 13% | ₹45 | 0.8969 | ₹41 |
| Year 2 | 13% | ₹51 | 0.8044 | ₹41 |
| Year 3 | 13% | ₹58 | 0.7214 | ₹42 |
| Year 4 | 13% | ₹65 | 0.6470 | ₹42 |
| Year 5 | 13% | ₹74 | 0.5803 | ₹43 |
2D Sensitivity Matrix (WACC vs Terminal Growth Rate)
Click any cell to apply WACC & terminal growth scenario. Values in ₹ / share.| WACC \ g(Terminal) | 3.0% | 4.0% | 4.5% | 5.0% | 6.0% |
|---|---|---|---|---|---|
| 10.0% | ₹175 -95% | ₹202 -94% | ₹218 -93% | ₹238 -93% | ₹293 -91% |
| 11.0% | ₹150 -95% | ₹169 -95% | ₹181 -94% | ₹194 -94% | ₹229 -93% |
| 11.5% | ₹140 -96% | ₹156 -95% | ₹166 -95% | ₹177 -95% | ₹206 -94% |
| 12.0% | ₹130 -96% | ₹145 -96% | ₹153 -95% | ₹163 -95% | ₹187 -94% |
| 13.0% | ₹115 -97% | ₹126 -96% | ₹132 -96% | ₹139 -96% | ₹157 -95% |
Discounted cash flow (DCF) and valuation models are quantitative projections based on user-supplied assumptions — not a forecast, not a guarantee of future performance, and not SEBI-registered investment advice. Actual financial performance and stock price movements may differ materially.
New to intrinsic valuation models? Learn how Discounted Cash Flow and Terminal Growth rates work.Read DCF Academy Guide →
Valuation history
P/E88.80current
ReportedComputed, approximate
P/B20.97current
ReportedComputed, approximate
The dashed line is computed from historical close price divided by the most recently reported annual EPS or book value — not IndianAPI's own figure, which only ever gives a single current reading with no history behind it. Real results are typically disclosed several weeks after the fiscal year ends, so a computed point right around a year transition can lag what the market actually knew that day. The solid line is the real reported figure.
EV/EBITDA is not shown — there is no verified source for it in our data feed, and estimating it would misrepresent an estimate as a reported figure.
| Date | P/E | P/B |
|---|---|---|
| 31 Aug 2026 | 88.80 | 20.97 |
Analyst Consensus, Price Targets & Forecasts
Analyst Consensus & Recommendations
Aggregated institutional equity research ratings · 31 Aug 2026
Strong Buy(1.67 / 5)
Strong Buy:3
Buy:2
Hold:1
Sell:0
Strong Sell:0
Coverage: 6 contributing analystsScale: 1 (Strong Buy) – 5 (Strong Sell)
Ratings shown are third-party analyst estimates compiled from institutional brokers. They do not constitute investment advice.
Risk Profile & Volatility
Statistical return volatility classification · 31 Aug 2026
High risk
Low RiskModerate RiskHigh Risk
Annualised Standard Deviation:53.65%
Analyst Price Targets
12-month forward price consensus · 31 Aug 2026
Upside: +19.43%
Mean Target₹3,916.00vs CMP ₹3,278.80
High Target₹4,500.00+37.2% max upside
Low Target₹3,550.008.3% downside
Median Target₹3,910.006 estimates
Low: ₹3,550.00Mean: ₹3,916.00High: ₹4,500.00
Mean Target Current Price (₹3,278.80)
Price targets are third-party analyst estimates compiled from institutional brokers. They do not constitute investment advice.
Forward Financial Forecasts & Consensus Estimates
Institutional broker consensus estimates and forward earnings trajectory
FY2024EConsensus
Mean Estimate
—
Low:—
High:—
FY2024EConsensus
Mean Estimate
—
Low:—
High:—
FY2024EConsensus
Mean Estimate
—
Low:—
High:—
FY2024EConsensus
Mean Estimate
—
Low:—
High:—
FY2025EConsensus
Mean Estimate
—
Low:—
High:—
FY2025EConsensus
Mean Estimate
—
Low:—
High:—
FY2025EConsensus
Mean Estimate
—
Low:—
High:—
FY2025EConsensus
Mean Estimate
—
Low:—
High:—
FY2026E2 Analysts
Mean Estimate
₹8.11
Low:—
High:—
FY2026E2 Analysts
Mean Estimate
₹8.88
Low:—
High:—
FY2026EConsensus
Mean Estimate
—
Low:—
High:—
FY2026EConsensus
Mean Estimate
—
Low:—
High:—
FY2027E2 Analysts
Mean Estimate
₹10.41
Low:—
High:—
FY2027E1 Analysts
Mean Estimate
₹17.94
Low:₹17.00
High:₹17.00
FY2027E1 Analysts
Mean Estimate
₹14.49
Low:₹14.00
High:₹14.00
FY2027E1 Analysts
Mean Estimate
₹14.13
Low:₹14.00
High:₹14.00
| Period / Fiscal Year | Consensus Mean | Bull Case (High) | Bear Case (Low) | Brokers |
|---|---|---|---|---|
| FY2024 Forecast | — | — | — | — |
| FY2024 Forecast | — | — | — | — |
| FY2024 Forecast | — | — | — | — |
| FY2024 Forecast | — | — | — | — |
| FY2025 Forecast | — | — | — | — |
| FY2025 Forecast | — | — | — | — |
| FY2025 Forecast | — | — | — | — |
| FY2025 Forecast | — | — | — | — |
| FY2026 Forecast | ₹8.11 | — | — | 2 |
| FY2026 Forecast | ₹8.88 | — | — | 2 |
| FY2026 Forecast | — | — | — | — |
| FY2026 Forecast | — | — | — | — |
| FY2027 Forecast | ₹10.41 | — | — | 2 |
| FY2027 Forecast | ₹17.94 | ₹17.00 | ₹17.00 | 1 |
| FY2027 Forecast | ₹14.49 | ₹14.00 | ₹14.00 | 1 |
| FY2027 Forecast | ₹14.13 | ₹14.00 | ₹14.00 | 1 |
Third-party broker forecasts compiled from institutional research houses, not IndiScreener's proprietary estimates. Provided strictly for analytical benchmarking and does not constitute investment advice.
Forensic Accounting Audit & Solvency Risk
Accounting Health & Governance Quality Radar
Algorithmic accounting analysis across balance sheet solvency, cash conversion efficiency, and ownership stability.
Clean Governance & Solvency
Financial Strengths & Catalysts
6 Factors- •Company has delivered a high Return on Equity (ROE) of 23.7%.
- •Company maintains conservative leverage with D/E of 0.25x.
- •Company has demonstrated healthy revenue growth of 17.7% CAGR over 3 years.
- •Net profit has grown at an impressive 69.1% CAGR over 3 years.
- •Strong cash generation: Operating Cash Flow is 132.8% of reported Net Profit.
- •High institutional backing: FIIs & DIIs hold a combined 30.2%.
Risk Factors & Watchouts
1 Watchout- •Stock is trading at an elevated valuation multiple of 88.8x P/E.
Forensic Accounting & Health Audit
Piotroski F-Score, Altman Z-Score Distress Model & Beneish Earnings Manipulation Checks
Piotroski F-Score9 / 9
● Strong (High Quality)
Altman Z-Score5.62
● Safe Zone
Negligible risk of financial distress over the next 2 years.
Beneish M-Score-2.90
● Low Risk (Clean Accounting)
Cash flows closely match reported earnings with conservative accruals.
Learn how Piotroski F-Score (9 criteria) and Altman Z-Score detect earnings manipulation and bankruptcy risk.Read Forensic Guide →
10-Year Financial Statements & DuPont ROE
Financial Statements
consolidated · amounts in ₹ Crores
Accounting Flow:
Wall Street Cash Flow & Free Cash Flow (FCF) Cascade
FY26 (2025-2026)3-Stage institutional flow from reported earnings to owner Free Cash Flow and capital allocation
FCF Conversion Rate (FCF / PAT)
23.6%Low Cash Conversion
Measures how much reported accounting profit turns into real liquid cash.
Free Cash Flow Margin
4.1%of Gross Revenue
Liquid cash retained per ₹100 of top-line revenue generated.
CapEx Reinvestment Rate
82.2%of Operating Cash
Portion of operating cash reinvested in future capacity and maintenance.
Reported Net Profit (PAT)₹170 CrInflow
170
+ D&A Non-Cash Charge₹49 CrAdd-back
49
Working Capital Adjustment₹7 Cr+ Cash
7
= Operating Cash Flow (CFO)₹226 CrOperating Cash
226
- Capital Expenditures (CapEx)-₹186 CrReinvestment
186
= Free Cash Flow (FCF)₹40 CrFree Cash Flow
40
- Dividends & Debt Repayment-₹37 CrCapital Return
37
= Net Change in Cash₹3 CrNet Balance
3
Multi-Year Historical FCF vs Reported PAT Trajectory:
Free Cash Flow (FCF) Reported Net Profit (PAT)
| Metric | 2018-201931 Mar 2019 | 2019-202031 Mar 2020 | 2020-202131 Mar 2021 | 2021-202231 Mar 2022 | 2022-202331 Mar 2023 | 2023-202431 Mar 2024 | 2024-202531 Mar 2025 | 2025-202631 Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹338.34 | ₹336.04 | ₹360.60 | ₹567.71 | ₹607.07 | ₹643.87 | ₹786.80 | ₹990.67 |
| Operating profit | ₹37.70 | ₹40.23 | ₹40.03 | ₹54.65 | ₹58.59 | ₹81.25 | ₹133.90 | ₹230.70 |
| OPM | 11.14% | 11.97% | 11.10% | 9.63% | 9.65% | 12.62% | 17.02% | 23.29% |
| Net profit | ₹19.28 | ₹23.59 | ₹22.02 | ₹35.27 | ₹35.15 | ₹57.29 | ₹93.12 | ₹169.91 |
| EPS | 4.64 | 5.68 | 5.29 | 8.04 | 7.66 | 12.48 | 20.22 | 36.83 |
| Net margin | 5.70% | 7.02% | 6.11% | 6.21% | 5.79% | 8.90% | 11.84% | 17.15% |
| ROE | 14.16% | 14.80% | 12.11% | 9.61% | 8.76% | 12.48% | 17.00% | 23.71% |
| ROCE | 19.50% | 16.61% | 12.33% | 11.21% | 12.09% | 14.69% | 21.76% | 29.37% |
| Debt / equity | 0.88 | 0.84 | 1.10 | 0.48 | 0.47 | 0.46 | 0.34 | 0.25 |
Compounded growth (CAGR)
| Metric | 1Y | 3Y | 5Y |
|---|---|---|---|
| Revenue | 25.91% | 17.73% | 22.40% |
| Net profit | 82.46% | 69.08% | 50.48% |
| EPS | 82.15% | 68.78% | 47.42% |
Each column only appears when 8 real reported years actually support it — never extrapolated from fewer.
Balance sheet
| Metric | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 | 2025-2026 |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₹311.57 | ₹381.47 | ₹467.04 | ₹677.20 | ₹692.68 | ₹782.46 | ₹932.62 | ₹1,146.74 |
| Total liabilities | ₹175.43 | ₹222.09 | ₹285.18 | ₹310.20 | ₹291.28 | ₹323.28 | ₹384.93 | ₹430.06 |
| Total equity | ₹136.14 | ₹159.38 | ₹181.87 | ₹367.00 | ₹401.40 | ₹459.17 | ₹547.69 | ₹716.67 |
| Total debt | ₹119.74 | ₹133.65 | ₹199.56 | ₹175.45 | ₹186.94 | ₹209.06 | ₹188.22 | ₹177.41 |
| Cash | ₹0.55 | ₹7.02 | ₹0.98 | ₹7.15 | ₹2.14 | ₹22.22 | ₹19.08 | — |
| Current assets | ₹136.28 | ₹153.21 | ₹176.83 | ₹300.23 | ₹237.71 | ₹267.20 | ₹385.60 | ₹450.14 |
| Current liabilities | ₹118.23 | ₹139.31 | ₹142.50 | ₹189.62 | ₹208.17 | ₹229.23 | ₹317.14 | ₹361.20 |
| Inventory | ₹43.84 | ₹54.87 | ₹70.91 | ₹115.18 | ₹79.60 | ₹90.40 | ₹150.29 | ₹150.78 |
| Receivables | ₹62.30 | ₹62.51 | ₹71.04 | ₹130.58 | ₹123.11 | ₹139.70 | ₹206.81 | ₹214.81 |
| Payables | ₹32.50 | ₹51.94 | ₹46.59 | ₹85.56 | ₹53.85 | ₹68.66 | ₹99.03 | ₹85.87 |
| Net PP&E | ₹146.68 | ₹192.12 | ₹243.91 | ₹340.09 | ₹398.02 | ₹451.39 | ₹476.94 | ₹606.13 |
| Retained earnings | ₹95.74 | ₹119.26 | ₹141.10 | ₹176.21 | ₹210.24 | ₹267.93 | ₹354.07 | ₹707.48 |
Cash flow
| Metric | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 | 2025-2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | ₹66.46 | ₹66.00 | ₹22.46 | ₹55.01 | ₹89.98 | ₹92.26 | ₹110.06 | ₹225.72 |
| Capital expenditure | ₹-64.83 | ₹-62.44 | ₹-83.03 | ₹-120.78 | ₹-111.64 | ₹-95.07 | ₹-72.22 | ₹-185.59 |
| Free cash flow | ₹1.63 | ₹3.56 | ₹-60.57 | ₹-65.77 | ₹-21.66 | ₹-2.81 | ₹37.84 | ₹40.13 |
| OCF / net profit | 3.45 | 2.80 | 1.02 | 1.56 | 2.56 | 1.61 | 1.18 | 1.33 |
| FCF / Capex intensity | 19.16 | 18.58 | 23.03 | 21.27 | 18.39 | 14.77 | 9.18 | 18.73 |
Income statement detail
| Metric | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 | 2025-2026 |
|---|---|---|---|---|---|---|---|---|
| Gross profit | ₹127.25 | ₹136.63 | ₹142.97 | ₹158.09 | ₹176.44 | ₹219.45 | ₹307.77 | ₹564.48 |
| Cost of revenue | ₹211.09 | ₹199.41 | ₹217.63 | ₹409.62 | ₹430.62 | ₹424.42 | ₹479.02 | ₹426.18 |
| EBITDA | ₹52.62 | ₹58.12 | ₹59.56 | ₹81.19 | ₹91.90 | ₹116.94 | ₹176.06 | ₹279.92 |
| Income before tax | ₹29.95 | ₹30.70 | ₹29.88 | ₹46.53 | ₹45.21 | ₹69.85 | ₹119.28 | ₹222.61 |
| Interest expense | ₹7.99 | ₹9.21 | ₹9.04 | ₹8.76 | ₹13.45 | ₹12.16 | ₹13.84 | ₹15.87 |
| Tax expense | ₹10.67 | ₹7.11 | ₹7.86 | ₹11.27 | ₹10.06 | ₹12.56 | ₹26.16 | ₹52.70 |
| D&A | ₹14.92 | ₹17.89 | ₹19.53 | ₹26.54 | ₹33.31 | ₹35.69 | ₹42.16 | ₹49.22 |
| EBITDA margin | 15.55% | 17.30% | 16.52% | 14.30% | 15.14% | 18.16% | 22.38% | 28.26% |
Financial ratios
| Metric | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 | 2025-2026 |
|---|---|---|---|---|---|---|---|---|
| Current ratio | 1.15 | 1.10 | 1.24 | 1.58 | 1.14 | 1.17 | 1.22 | 1.25 |
| Quick ratio | 0.78 | 0.71 | 0.74 | 0.98 | 0.76 | 0.77 | 0.74 | 0.83 |
| Interest coverage | 4.72 | 4.37 | 4.43 | 6.24 | 4.36 | 6.68 | 9.67 | 14.54 |
| Inventory days | 75.80 | 100.43 | 118.93 | 102.63 | 67.47 | 77.74 | 114.52 | 129.13 |
| Receivable days | 67.21 | 67.90 | 71.91 | 83.95 | 74.02 | 79.19 | 95.94 | 79.14 |
| Payable days | 56.20 | 95.07 | 78.14 | 76.24 | 45.64 | 59.05 | 75.46 | 73.54 |
| Cash conversion cycle | 86.82 | 73.26 | 112.70 | 110.35 | 95.85 | 97.89 | 135.00 | 134.74 |
| Working capital days | — | — | — | — | — | — | — | — |
| Fixed asset turnover | 2.31 | 1.75 | 1.48 | 1.67 | 1.53 | 1.43 | 1.65 | 1.63 |
| ROA | 6.19% | 6.18% | 4.71% | 5.21% | 5.07% | 7.32% | 9.98% | 14.82% |
| ROIC | 9.50% | 10.81% | 7.75% | 7.74% | 7.77% | 10.32% | 14.58% | — |
| Gross margin | 37.61% | 40.66% | 39.65% | 27.85% | 29.06% | 34.08% | 39.12% | 56.98% |
DuPont 3-Stage ROE Factor Decomposition
Deconstructing Return on Equity into Profitability, Asset Efficiency, and Financial Leverage
Balanced Return EngineFY2025-2026
Net marginProfitability
17.15%
Net Profit generated per ₹100 of revenue (Profitability)
×
Asset turnoverEfficiency
0.86
Revenue generated per ₹1 of total assets (Capital Efficiency)
×
Equity multiplierLeverage
1.60
Total assets supported per ₹1 of shareholder equity (Leverage)
=
Implied DuPont ROEFinal Output
23.71%
Reported: 23.71%
Explore the 3-Stage DuPont Formula: Net Margin × Asset Turnover × Leverage Multiplier.Read DuPont Guide →
Corporate Actions, Dividends & Capital Changes
Chronological Corporate Actions Registry
Historical stock splits, bonus shares, rights issues, and corporate schemes
| Year | Execution Date | Action Type | Ratio / Term |
|---|---|---|---|
| 2026 | 11 Sept 2026 | dividend | 150% |
| 2025 | 19 Sept 2025 | dividend | 100% |
| 2024 | 15 Sept 2024 | dividend | 50% |
| 2023 | 23 Nov 2023 | split | 2:10 |
| 2018 | 04 Aug 2018 | dividend | 75% |
| 2017 | 01 Sept 2017 | dividend | 50% |
| 2016 | 26 Jul 2016 | dividend | 40% |
| 2015 | 01 Aug 2015 | dividend | 20% |
| 2008 | 17 Sept 2008 | dividend | 5% |
| 2007 | 14 Aug 2007 | dividend | 10% |
| 2006 | 26 May 2006 | dividend | 8% |
Dividend Intelligence & Capital Return History
Historical cash payout track record across 3 dividend distributions
Latest Year DPS:₹3.00
Yield on CMP:0.09%
Annual Dividend Payout Progression (Per Share)Total Cumulative DPS: ₹6.00
₹3.0
2026
₹2.0
2025
₹1.0
2024
| Ex-Date | Amount (Per Share) | Dividend Type |
|---|---|---|
| 11 Sept 2026 | ₹3.00 | Final |
| 19 Sept 2025 | ₹2.00 | Final |
| 13 Sept 2024 | ₹1.00 | Final |
Industry Peer Group & Valuation Spread
Compare valuation multiples and market cap relative to sector competitors
Consumer DurablesCompare Peers in Studio
Market Cap15,352.62 ₹ cr
Beats 60% of 40 industry peers · median 12,557.58 ₹ cr
P/E88.80 x
Beats 89% of 35 industry peers · median 46.03 x
P/B20.97 x
Beats 97% of 36 industry peers · median 5.98 x
ROE23.71%
Beats 80% of 40 industry peers · median 12.24%
ROCE29.37%
Beats 78% of 40 industry peers · median 14.16%
Debt to Equity0.25 x
Beats 35% of 40 industry peers · median 0.38 x
Net Margin17.15%
Beats 95% of 40 industry peers · median 9.79%
Dividend Yield0.15%
Beats 7% of 29 industry peers · median 0.62%
Revenue Growth (YoY)13.77%
Beats 41% of 39 industry peers · median 18.41%
| Company | Market Cap ▼ | P/E | P/B |
|---|---|---|---|
Titan Company Ltd.TITAN | ₹4.55 L | 90.44 | 29.30 |
Asian Paints Ltd.ASIANPAINT | ₹2.47 L | 57.83 | 11.70 |
LG Electronics India Ltd.LGEINDIA | ₹1.15 L | 68.13 | 14.98 |
| ₹90,031.78 | 54.39 | 19.05 | |
Havells India Ltd.HAVELLS | ₹77,108.50 | 45.39 | 8.11 |
Peers are chosen strictly by industry classification. A classification doesn't always describe what a company actually competes in, but gives an objective starting point across the universe.
Regulatory Filings & Market Intelligence
Corporate Document & Filings Vault
No statutory exchange announcements or PDF filings have been recorded for SHAILY yet.
News
- IndianAPIUpcoming IPO: Bharat PET receives SEBI approval to raise ₹760 crore through public issue
Bharat PET Limited has received SEBI approval for its IPO to raise ₹760 crore. The offering includes a fresh issue of ₹120 crore and an OFS of ₹640 crore, involving selling shareholders. Proceeds will fund debt repayment and capital expenditures.
- IndianAPIStocks to buy for the long term: Axis Bank, Delhivery among Ventura's top picks with 19% to 58% upside
Vinit Bolinjkar of Ventura shares top stock picks for the long term, highlighting companies like Ather Energy and Axis Bank. With potential upsides between 19%-58%, these picks are solid bets for investors looking to navigate turbulent waters and capitalise on emerging opportunities.
- IndianAPIStocks to buy for short term: Aegis Logistics, CG Power, NBCC among 5 stocks experts recommend for next 1-2 weeks
Stocks to buy for the short term: Experts from Master Capital Services and Choice Broking suggest five stocks with strong bullish indicators for short-term investment. Discover which stocks could potentially yield gains over the next 1-2 weeks.
- IndianAPISmall-cap multibagger stock jumps over 5% on order win. Do you own?
Shaily Engineering Plastics share price has fallen 24% in three months and has dropped 7% in six months. However, the smallcap stock has risen 32% in one year, and has delivered multibagger returns of 283% in two years.
- IndianAPIThese two companies will sell shovels during India’s semaglutide gold rush
Shaily Engineering Plastics Ltd and Gland Pharma Ltd, involved in the making and filling of injectable pens for semaglutide, stand to win big as patients will need these devices irrespective of which brand of the drug they choose.
- IndianAPIUBS sees 60% more upside in Shaily Engineering after a massive 700% rally in two years. Here's why
UBS has initiated coverage of Shaily Engineering Plastics with a 'Buy' rating and a target price of ₹4,000, indicating a 60% upside. The firm highlights Shaily's patented technology and strong market position for GLP-1 therapies, estimating substantial revenue growth and a 75% EPS CAGR by FY28.
- IndianAPIAshish Kacholia raises stake in this small cap multibagger stock in Q2. Do you own?
As of September 2025, Ashish Kacholia’s portfolio comprises 42 stocks valued at around ₹2,088 crore, with the largest holding in Shaily Engineering Plastics, where he owns 14.79 lakh shares, representing a 3.22% stake valued at ₹366.2 crore.
- IndianAPIBreakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today - 25 August 2025
Sumeet Bagadia recommends five breakout stocks to buy today: KRN Heat Exchanger and Refrigeration, Avantel, Shaily Engineering Plastics, Datamatics Global Services, and Fedbank Financial Services.
For informational and educational purposes only. Not investment advice. Data may be delayed or incomplete. Consult a SEBI-registered investment adviser before making investment decisions.